News and Announcements
MedAdvisor Signs Pfizer for Patient Engagement Program
- Published December 08, 2016 10:27AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th December 2016 – ASX Announcement
- MedAdvisor signs Pfizer, the world’s largest research-based pharmaceutical company to deliver a patient engagement program (PEP) on its platform
- Pfizer will use the MedAdvisor platform to deliver information and advice to patients to enhance and promote the safe and effective use of its medication
- Pfizer develops, manufactures and distributes hundreds of prescription medicines, vaccines and over-the-counter products
- Agreement with Pfizer and renewed programs provide strong validation of the value the PEPs are delivering pharmaceutical manufacturers and the Company’s ability to grow this revenue stream
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has entered into an agreement with Pfizer Australia Pty Limited (Pfizer) to provide a Patient Engagement Program (PEP) for one of its leading medications.
MedAdvisor will work with Pfizer to deliver important information and guidance to patients prescribed with this Pfizer medication. Preparation for the program has already commenced and it will run for an initial period of 18 months.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
